You must have missed this in the results announcement:
Sustained growth in revenue and earnings expected in H2 FY17
Commenting on RXP’s outlook, Mr Fielding said:
“We will continue to evolve our organisation and our capabilities to ensure we remain well placed to meet the needs of our clients. Our innovative approach to client work has enabled us to develop and maintain a strong pipeline of work in and across our specialisations and we look forward to H2 FY17 and beyond with confidence.
“In an industry that continues to consolidate, our strong balance sheet positions us well in terms of pursuing further targeted acquisitions.
“We expect FY17 revenue growth to be at the top end of the original 10-15% guidance with an underlying EBITDA margin target of 13-14%, and we remain committed to our progressive dividend policy.”
RXP Price at posting:
76.0¢ Sentiment: Buy Disclosure: Held